Aaron Green Acquires 18,702 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMDGet Free Report) CEO Aaron Green bought 18,702 shares of the company’s stock in a transaction on Monday, June 15th. The shares were acquired at an average cost of $0.54 per share, for a total transaction of $10,099.08. Following the completion of the acquisition, the chief executive officer directly owned 1,859,725 shares of the company’s stock, valued at $1,004,251.50. This trade represents a 1.02% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Aaron Green also recently made the following trade(s):

  • On Friday, June 12th, Aaron Green bought 36,920 shares of OneMedNet stock. The shares were acquired at an average cost of $0.56 per share, for a total transaction of $20,675.20.

OneMedNet Stock Performance

Shares of NASDAQ:ONMD opened at $0.60 on Thursday. The company’s fifty day moving average is $0.85 and its two-hundred day moving average is $0.95. The stock has a market capitalization of $32.78 million, a price-to-earnings ratio of -12.05 and a beta of 1.12. OneMedNet Corporation has a 1-year low of $0.33 and a 1-year high of $4.22.

OneMedNet (NASDAQ:ONMDGet Free Report) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.04) EPS for the quarter. The firm had revenue of $0.10 million for the quarter.

Analysts Set New Price Targets

Several equities analysts have recently commented on ONMD shares. Wall Street Zen lowered shares of OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

Check Out Our Latest Report on OneMedNet

Hedge Funds Weigh In On OneMedNet

Institutional investors and hedge funds have recently bought and sold shares of the stock. State Street Corp grew its position in OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after buying an additional 34,200 shares in the last quarter. Jane Street Group LLC bought a new position in OneMedNet in the 4th quarter valued at about $119,000. Virtu Financial LLC bought a new position in OneMedNet in the 4th quarter valued at about $48,000. HRT Financial LP bought a new position in OneMedNet in the 4th quarter valued at about $32,000. Finally, Exencial Wealth Advisors LLC grew its position in OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after buying an additional 45,401 shares in the last quarter. Institutional investors own 0.95% of the company’s stock.

About OneMedNet

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Featured Stories

Insider Buying and Selling by Quarter for OneMedNet (NASDAQ:ONMD)

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.